FMC - Streator Chain: Fresenius Medical Care Location: 2356 N. Bloomington St., Streator, Illinois, 61364 Rating: Phone: (815) 673-2200 |
News Archive
Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced it has begun receiving funds from a biotech-oriented investment group called BIOTECH Development Partners, LLC.
Quanterix announced that it will be presenting at the 21st Annual Needham Growth Conference, at the Lotte New York Palace Hotel, New York City.
Imagine that you witness a crime. The police investigator brings you to the police station to obtain an official statement, but between the crime and your official witness statement, you are exposed to other (potentially inaccurate) information about the crime. Before administering the criminal interview, the investigator asks you a litany of mundane demographic questions in a dry and uninterested manner, then moves directly into the interview about the crime. Would you feel comfortable? Most importantly, would your report be accurate and detailed, uninfluenced by the outside information you received?
Most school text books contain messages about health, but 24.6% of these are not based on any scientific evidence, according to a study by the Knowledge Management Unit at Baza Hospital (Granada), published in the journal BMC Public Health.
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer. Known as AFFIRM, the trial will evaluate the novel androgen receptor antagonist MDV3100 in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.
› Verified 3 days ago
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. Dialysis facility in medicare covers outpatient maintenance dialysis treatments, training for self-dialysis, self-dialysis support services and self-dialysis equipment and supplies. In some cases, Medicare may cover ambulance transportation when the patient has End-Stage Renal Disease (ESRD), need dialysis, and need ambulance transportation to or from a dialysis facility.
The star rating shows how well a dialysis center delivers care compared to the national average, based on Medicare data. Each dialysis center receives a rating between 1 and 5 stars, with 3 stars representing the national average. A five-star rating means a center has quality of care that is considered 'much above average' compared to other dialysis facilities. A one or two-star rating means that measured health outcomes for that center were below average. The star rating is part of Medicare's work to make data on the quality of patient care easier to understand and use. Patient survey results aren't included in the star rating.